| Industry | 文化、体育和娱乐业 | ||||||||||||||||||||||||
| Company Introduction | 慈文传媒创办于2000年，2015年11月登陆中国A股市场，系国内第一批被授予电视剧制作经营许可证(甲种)的民营影视公司。吴卫东任董事长，马中骏慈文传媒创始人、首席内容官。 以“互联网+”为DNA，充分发掘中华优秀传统文化当代价值，综合运用电视剧、电影、动漫、游戏、舞台艺术等现代多元文化艺术形式，向全球精彩展示、生动传播中国故事与时代价值，同时拥有影视、动漫、游戏、经纪等多家成员公司的大型泛娱乐传媒集团。慈文传媒主要从事影视剧的投资、制作、发行及衍生业务，移动休闲游戏研发推广和渠道推广业务及艺人经纪业务。公司已形成了以自有IP为核心资源，以电视剧投资、制作及发行业务为核心，积极延伸拓展电影、游戏、综艺和艺人经纪等相关业务领域，并形成了各业务板块良性互动、协同发展的业务体系。 自2000年成立以来，慈文传媒始终秉承“讲好中国故事，展现东方审美，面向世界表达”的理想和理念，坚持精品原创和IP开发并重，推进精品IP的培育和开发，优化产品结构，丰富剧作题材，提升制作品质，累计出品剧集100余部，综艺4档。公司持续打造网台联动的头部剧和精品原创剧，先后出品《神雕侠侣》《射雕英雄传》《花千骨》《老九门》《楚乔传》《光荣时代》《三叉戟》等精品剧作。其中《花千骨》项目是按照贯通泛娱乐全产业链的思路而整体策划，经过精心培育和运营，已然成为超级品牌，不仅做出了现象级电视剧，而且是全产业链转化最好、完成度最高的案例，刷新了业内多项记录；2016年投资制作《老九门》，第一个实现实现单网独播剧播放量突破120亿，会员拉动数量相当于两个《太阳的后裔》，创造记录；2017年投资制作《楚乔传》，缔造“楚乔现象”，成为IP改编中国第一部女性励志传奇古装剧，以收官时播放量429亿创造记录。 2019年2月，国资入股，江西出版集团旗下华章投资集团控股，江西省人民政府成为实际控制人。“混改”互补共生，助力慈文传媒调整产业结构、优化资源配置、升级产出内容，深耕各大内容业务板块，整合各类渠道资源，推动各业务板块的协同发展，与优爱腾等视频网站及一线卫视长期建立友好合作，与一线渠道合作升级，不断拓展新领域：如与东方卫视共同打造大型综艺《中国梦之声·我们的歌》《舞者》；与视频平台爱奇艺签订战略合作协议。持续打造慈文“品牌+”的泛娱乐平台，从传统影视娱乐内容提供商升级为“泛娱乐产业优质运营商”。 | ||||||||||||||||||||||||
| Main Business | 广播电视节目制作经营，摄影服务，文化教育信息咨询，经营演出及经纪业务等。 | ||||||||||||||||||||||||
| Legal Representative | 周敏 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 翁志超 | ||||||||||||||||||||||||
| Solicitors | 北京市金杜律师事务所 | ||||||||||||||||||||||||
| Auditors | 众华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 010-84409922 | ||||||||||||||||||||||||
| Fax No | 010-84409922-821 | ||||||||||||||||||||||||
| Website | www.ciwen.com.cn | ||||||||||||||||||||||||
| ciwen@ciwen.tv；wengzhichao@ciwen.tv；luoshimin@ciwen.tv | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 26/01/2010 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.060 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 2.036 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 2.897B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |